Hepatalin-S

Trademark usage description

pharmaceutical compound, namely a synthesized form of the naturally occurring hormone known as hepatic insulin-sensitizing substance research and de Read More

Classification Information

Class [005]
Pharmaceutical compound, namely a synthesized form of the naturally occurring hormone known as hepatic insulin-sensitizing substance

Classification kind code

Class [042]
Research and development, and technical project studies concerning the treatment of metabolic syndrome, diabetes, complications from diabetes, and insulin resistance

Classification kind code

Mark Details

Serial Number

2103833

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 29^th Jan 2025	Advertised
Submitted for opposition 26 on 3^rd Jan 2025	Approved
Submitted for opposition 27 on 3^rd Jan 2025	Approval Notice Sent
Submitted for opposition 22 on 23^rd Dec 2024	Search Recorded
Submitted for opposition 287 on 4^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 30^th Apr 2021	Filed
Submitted for opposition 1 on 30^th Apr 2021	Created
Submitted for opposition 31 on 30^th Apr 2021	Formalized

Hepatalin-S

Classification Information

Class [005]Pharmaceutical compound, namely a synthesized form of the naturally occurring hormone known as hepatic insulin-sensitizing substance

Classification kind code

Class [042]Research and development, and technical project studies concerning the treatment of metabolic syndrome, diabetes, complications from diabetes, and insulin resistance

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical compound, namely a synthesized form of the naturally occurring hormone known as hepatic insulin-sensitizing substance

Class [042]
Research and development, and technical project studies concerning the treatment of metabolic syndrome, diabetes, complications from diabetes, and insulin resistance